Cleared Traditional

K181718 - BD FlowSmart Set/MiniMed Pro-Set

K181718 is an FDA 510(k) clearance for BD FlowSmart Set/MiniMed Pro-Set, manufactured by Becton, Dickinson and Company. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 111-day FDA review.

K181718 · Becton, Dickinson and Company · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2018
Decision
111d
Days
Class 2
Risk

K181718 is an FDA 510(k) clearance for the BD FlowSmart Set/MiniMed Pro-Set. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Becton, Dickinson and Company (Franklin Lakes, US). The FDA issued a Cleared decision on October 18, 2018 after a review of 111 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Becton, Dickinson and Company devices

FDA 510(k) Submission Details - K181718

510(k) Number K181718 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 29, 2018
Decision Date October 18, 2018
Days to Decision 111 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
18d faster than avg
Panel avg: 129d · This submission: 111d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 532
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K181718.
Velano Vascular Q2 Extension Set
K182897 · Velano Vascular · Mar 2019
Infusion Sets with Precision Filter for Single Use, Precision Infusion Filter for Single Use, Extended Infusion Sets for Single Use
K181870 · Wuhan W.E.O Science & Technology Development Co., Ltd. · Feb 2019
Tamper Evident Cap with Male Luer Lock
K182545 · International Medical Industries, Inc. · Jan 2019
AMSafe Sure-Lok Needle-Free Connector
K173665 · Amsino International, Inc. · Sep 2018
IV Administration Set
K173361 · B.Braun Medical, Inc. · Jun 2018
MiniMed Mio Advance infusion set
K173879 · Unomedical A/S · Mar 2018